人工智能在肝细胞癌外科诊疗领域的应用进展
作者:
作者单位:

1.深圳市人民医院(南方科技大学第一附属医院/暨南大学第二临床医学院)肝胆胰外科,广东深圳 518020 2.清华大学附属北京清华长庚医院肝胆胰中心,清华大学精准医学研究院,数智肝胆病学教育部重点实验 室,北京 102218

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金重大项目(82090052),清华大学精准医学科研项目(2022ZLA007)


The application progress of artificial intelligence in surgical diagnosis and treatment of hepatocellular carcinoma
Author:
Affiliation:

1. Department of Hepatobiliary and Pancreatic Surgery, Shenzhen People’s Hospital (First Affiliated Hospital of Southern University of Science and Technology / Second Clinical College of Jinan University), Shenzhen 518020,China 2. Hepatobiliary Center, Beijing Tsinghua Changgeng Hospital, Affiliated Hospital of Tsinghua University, Tsinghua University Institute of Precision Medicine, Key Laboratory of Digital Hepatobiliary Diseases of Ministry of Education, Beijing 102218,China

Fund Project:

undefined

  • 摘要
  • 图/表
  • 访问统计
  • 参考文献
  • 相似文献
  • 引证文献
  • 资源附件
  • 文章评论
    摘要:

    肝细胞癌(HCC)是全球高发且预后较差的恶性肿瘤之一,外科手术仍是其根治性治疗的核心手段。 传统诊疗模式在精准评估、个体化决策及术后管理方面面临诸多挑战。近年来,人工智能(AI)技术,尤其是深度学 习与影像组学的快速发展,为HCC外科诊疗全流程带来了系统性变革。本文系统综述了AI在HCC外科领域的最 新研究进展,阐明其在精准诊断、外科治疗决策与手术规划、综合治疗策略制定、术后管理与预后预测中的应用价 值。研究表明,AI可有效提高病灶识别精度、优化手术策略、降低围术期风险,并支持术后个体化随访与精准化干 预。当前相关应用在临床实践中仍受数据规范不足、外部验证有限、临床可解释性较弱等问题制约,但其在推动 HCC外科诊疗向智能化、精准化、个体化方向发展的潜力巨大。未来需通过多中心协作、高质量数据共建及可解释 AI技术的突破,进一步促进AI在肝癌外科中的深度融合与规范应用,为提升患者生存率与生活质量提供有力支撑。

    Abstract:

    Hepatocellular carcinoma (HCC) is one of the most highly prevalent and poorly prognosed malignant tumors worldwide, and surgical intervention remains the core treatment method. The conventional diagnositic and therapeutic approaches faces numerous challenges in precise assessment, individualized decision-making, and postoperative management. In recent years, artificial intelligence (AI) technology, especially the rapid development of deep learning and radiomics, has introduced systematic changes to the entire process of HCC surgical diagnosis and treatment. This article systematically reviews the latest research advancements of AI in the field of HCC surgery, clarifying its application value in enhancing diagnostic precise, informing surgical treatment decision-making and planning, formulating comprehensive treatment strategy, and improving postoperative management and prognosis prediction. Studies have shown that AI can effectively improve lesion recognition accuracy, optimize surgical strategies, reduce perioperative risks, and facilitate individualized follow-up and precise postoperative intervention. Currently, the related applications in clinical practice remain limited due to insufficient data standardization, limited external validation, and weak clinical interpretability. However, its potential to promote the development of HCC surgical diagnosis and treatment towards intelligence, precision, and individualization is enormous. In the future, further integration and standardized application of AI in liver cancer surgery should be promoted through multi-center collaboration, highquality data collaboration, and breakthroughs in interpretable AI technology, providing strong support for improving patient survival rates and quality of life.

    参考文献
    相似文献
    引证文献
引用本文

何泳铸,杨世忠.人工智能在肝细胞癌外科诊疗领域的应用进展[J].广东医科大学学报,2026,44(4):421-430.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-08-02
  • 出版日期:

扫码关注

官方微信

温馨提示,谨防上当受骗!
关闭